Skip to content

Effect of oral consumption of Lactobacillus paracasei on postoperative pain of patients after hemorrhoidectomy

Effect of oral consumption of Lactobacillus paracasei on postoperative pain of patients after hemorrhoidectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097163
Enrollment
Unknown
Registered
2025-02-13
Start date
2025-02-13
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoids

Interventions

Experimental group:Starting 14 days before surgery, Lactobacillus paracasei is administered three times per day, once a sachet, dissolved in warm water (35-40°C) before consumption.
Control group:Starting 14 days before surgery, heat-inactivated Lactobacillus paracasei is administered three times a day, once a sachet, dissolved in warm water (35-40°C) before consumption.

Sponsors

Shenzhen People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients aged 18-70 years with mixed hemorrhoids, scheduled to undergo mixed hemorrhoidectomy (Milligan-Morgan procedure) in the colorectal surgery department; (2) No mental disorders and capable of normal communication; (3) Willing to participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) History of severe intestinal diseases (e.g., Crohn’s disease, ulcerative colitis); (2) Known immune deficiency; (3) Patients using antibiotics or immunosuppressants; (4) Patients with severe systemic diseases (e.g., severe cardiac, hepatic, or renal insufficiency); (5) Pregnant women, women within 6 months postpartum, or currently breastfeeding; (6) Patients with alcohol addiction; (7) Women of childbearing age planning to become pregnant during the study period; (8) Currently participating in another clinical study or having completed one within the past 60 days; (9) Unable to understand and comply with study requirements; (10) Patients requiring prolonged bed rest after surgery; (11) Other reasons deemed unsuitable for enrollment by the investigator.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;

Secondary

MeasureTime frame
Usage rate and intensity of analgesic medications;Incidence of urinary retention;Incidence of defecation difficulty;Postoperative quality of life score (SF-36);APS-POQ-R score;

Countries

China

Contacts

Public ContactBiaohuan Zhou

Shenzhen People's Hospital

bh_zhou@szhospital.com+86 1392662875

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026